1. Robert Sinha, M.D. Radiation OncologistWestern Radiation OncolgyDorothy Schneider Cancer Center 2.  Incidence: Estimated 226,160 new cases in 2012 Mortality: Estimated…

1. From metagenes to biomarkers, a possibleapproach for prognosis and personalized medication through GWAS of lung cancer (NSCLC)Cheng Luo, Ph. D University of Tartu 2. 1,…

1. Acute Liver failure Wahid Altaf 2. Case…Thursday evening call from AnE registrar  Mr C.E. 56 Year old male.  Presenting complaint of Jaundice Confusion Feeling…

1. Predicting Clinical and Biochemical Endpoints after Radical Prostatectomy Andrew J. Stephenson, MD FRCSC FACS Director, Urologic Oncology Glickman Urological and Kidney…

1. Tyverb ®(lapatinib): Introduction and BackgroundTYV/SLK/08/39072/1 Date of preparation: Nov 2008 Prescribing information can be foundat the end of the full slide set…

1. SYMPOSIUMTRASTUZUMAB IN EARLY BREAST CANCER 29/05/2012 DR. R. RAJKUMARII YR POST GRADUATE DEPT OF MEDICAL ONCOLOGY MADRAS MEDICAL COLLEGECHENNAI 2. QUESTION• Trastuzumab:…

Slide 1Bevacizumab in MBC 1 Breast Cancer Take home message Sabino De Placido Slide 2 Survival of Patients with Metastatic Breast Cancer 1974 - 2000 Slide 3 International…

Slide 1BOOK02665/07 AKI in Pediatrics Patrick D. Brophy MD Associate Professor University of Iowa- Carver College of Medicine Dept. of Pediatrics Division of Nephrology,…

Slide 1Facial Nerve Repair / Parotid Cancer © Orlando Guntinas-Lichius 2008 Indications for Preservation, Resection and Reconstruction of the Facial Nerve in Parotid Cancer…

Slide 1Phase II study of Erbitux, CisPlatin, Epirubicin, Leucovorin with UFT (E-PELUF) as neoadjuvant treatment in patients with gastric cancer Dr Efraim Idelevich MD, PhD…